<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02591979</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-PAS-2013-151</org_study_id>
    <nct_id>NCT02591979</nct_id>
  </id_info>
  <brief_title>PASHOS Project: Advanced Platform for Sleep Apnea Syndrome Assessment</brief_title>
  <official_title>PASHOS Project: Advanced Platform for Sleep Apnea Syndrome Assessment. A Multi-Centre Study to Validate a Sleep Apnea Screening Model in Primary Health Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to develop and validate a work-model in Primary Health Care for
      identifying patients with Sleep Apnea Syndrome, based on clinical variables and an ambulatory
      monitoring study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Actual">October 2018</completion_date>
  <primary_completion_date type="Actual">October 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>Apnea/Hypopnea Index</measure>
    <time_frame>At baseline</time_frame>
    <description>At primary healthcare</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Apnea/Hypopnea Index</measure>
    <time_frame>At 3 months</time_frame>
    <description>At Sleep Lab Unit</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular risk factors</measure>
    <time_frame>At baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>History of cardiovascular or cerebrovascular disease</measure>
    <time_frame>At baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung function tests</measure>
    <time_frame>At baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-perceived sleepiness. Epworth Test</measure>
    <time_frame>At baseline</time_frame>
    <description>At primary healthcare</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-perceived sleepiness. Epworth Test</measure>
    <time_frame>At 3 months</time_frame>
    <description>At Sleep lab unit</description>
  </secondary_outcome>
  <enrollment type="Actual">198</enrollment>
  <condition>Sleep Apnea Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients visited at Primary Care consultations will be included according to a
        randomization schedule to reach the necessary sample.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients between 18 to 75 years.

        Exclusion Criteria:

          -  Cognitive impairment or psycho-physical deterioration that impede to perform
             ambulatory monitoring study.

          -  Worsened or unstable cardiovascular or cerebrovascular disease.

          -  Chronic insomnia (&lt;5h sleep / day).

          -  Relevant respiratory comorbidity that could interfere with arterial saturation
             measurements, as moderate to severe chronic obstructive pulmonary disease.

          -  Neuromuscular disease.

          -  Refusal to participate in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>October 27, 2015</study_first_submitted>
  <study_first_submitted_qc>October 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 30, 2015</study_first_posted>
  <last_update_submitted>March 3, 2019</last_update_submitted>
  <last_update_submitted_qc>March 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sleep Apnea Syndrome</keyword>
  <keyword>Primary Health Care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

